3 days popular7 days popular1 month popular3 months popular

‘Immune Camouflage’ may explain H7N9 influenza vaccine failure

The avian influenza A (H7N9) virus has been a major concern since the first outbreak in China in 2013. Due to its high rate of lethality and pandemic potential, H7N9 vaccine development has become a priority for public health officials. However, candidate vaccines have failed to elicit the strong immune responses necessary to protect from [...]

Immune system may be pathway between nature and good health

Research has found evidence that spending time in nature provides protections against a startling range of diseases, including depression, diabetes, obesity, ADHD, cardiovascular disease, cancer, and many more. How this exposure to green space leads to better health has remained a mystery. After reviewing hundreds of studies examining nature’s effects on health, University of Illinois [...]

Switched before birth: Study shows protein creates tumor-fighting cells

Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor–a specialized protein which communicates signals between a cell and the outside world–can mobilize immune cells to attack, rather than protect, malignant tumors. The researchers report their findings [...]

UF Health researchers work to develop Type 1 diabetes vaccine

Vaccines exist to protect against many maladies – flu, chickenpox and polio, among others. University of Florida Health researchers hope to soon add Type 1 diabetes to that list. The researchers recently published two papers that explore different methods of delivering a vaccine for Type 1 diabetes, both of which prevented 40 percent of the [...]

Which patients will respond to melanoma immunotherapy?

Patients with metastatic melanoma who have benefited from a new type of cancer immunotherapy don’t appear to share the same tumor-produced antigens, according to a new report by Eliezer Van Allen and colleagues. If the molecular targets for the immunotherapy differ from patient to patient, as this study suggests, it may be difficult to predict [...]